[HTML][HTML] Role of the NLRP3 inflammasome in autoimmune diseases
Z Li, J Guo, L Bi - Biomedicine & pharmacotherapy, 2020 - Elsevier
NOD-like receptor family pyrin domain containing 3 (NLRP3) is an intracellular receptor that
senses foreign pathogens and endogenous danger signals. It assembles with apoptosis …
senses foreign pathogens and endogenous danger signals. It assembles with apoptosis …
[HTML][HTML] Genetic–epigenetic interactions in cis: a major focus in the post-GWAS era
Studies on genetic–epigenetic interactions, including the mapping of methylation
quantitative trait loci (mQTLs) and haplotype-dependent allele-specific DNA methylation …
quantitative trait loci (mQTLs) and haplotype-dependent allele-specific DNA methylation …
[HTML][HTML] Genotyping array design and data quality control in the Million Veteran Program
The Million Veteran Program (MVP), initiated by the Department of Veterans Affairs (VA),
aims to collect biosamples with consent from at least one million veterans. Presently, blood …
aims to collect biosamples with consent from at least one million veterans. Presently, blood …
[HTML][HTML] Inflammasome and its therapeutic targeting in rheumatoid arthritis
Q Jiang, X Wang, E Huang, Q Wang, C Wen… - Frontiers in …, 2022 - frontiersin.org
Inflammasome is a cytoplasmic multiprotein complex that facilitates the clearance of
exogenous microorganisms or the recognition of endogenous danger signals, which is …
exogenous microorganisms or the recognition of endogenous danger signals, which is …
Mechanisms underlying DMARD inefficacy in difficult-to-treat rheumatoid arthritis: a narrative review with systematic literature search
NMT Roodenrijs, PMJ Welsing, J van Roon… - …, 2022 - academic.oup.com
Management of RA patients has significantly improved over the past decades. However, a
substantial proportion of patients is difficult-to-treat (D2T), remaining symptomatic after …
substantial proportion of patients is difficult-to-treat (D2T), remaining symptomatic after …
[HTML][HTML] Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis
S Bek, AB Bojesen, JV Nielsen, J Sode… - The …, 2017 - nature.com
Rheumatoid arthritis (RA) is a chronic inflammatory disease that affects~ 1% of the
Caucasian population. Over the last decades, the availability of biological drugs targeting …
Caucasian population. Over the last decades, the availability of biological drugs targeting …
[HTML][HTML] Cell-free DNA in rheumatoid arthritis
T Hashimoto, K Yoshida, A Hashiramoto… - International journal of …, 2021 - mdpi.com
Endogenous DNA derived from the nuclei or mitochondria is released into the bloodstream
following cell damage or death. Extracellular DNA, called cell-free DNA (cfDNA), is …
following cell damage or death. Extracellular DNA, called cell-free DNA (cfDNA), is …
[HTML][HTML] Genetic polymorphisms associated with rheumatoid arthritis development and antirheumatic therapy response
DS Mikhaylenko, MV Nemtsova, IV Bure… - International journal of …, 2020 - mdpi.com
Rheumatoid arthritis (RA) is the most common inflammatory arthropathy worldwide. Possible
manifestations of RA can be represented by a wide variability of symptoms, clinical forms …
manifestations of RA can be represented by a wide variability of symptoms, clinical forms …
Polymorphisms in the NF kB, TNF‐alpha, IL‐1beta, and IL‐18 pathways are associated with response to anti‐TNF therapy in Danish patients with inflammatory bowel …
S Bank, M Julsgaard, OK Abed… - Alimentary …, 2019 - Wiley Online Library
Background Anti‐tumor necrosis factor‐α (TNF‐α) is used for the treatment of severe cases
of IBD, including Crohn's disease (CD) and ulcerative colitis (UC). However, one‐third of the …
of IBD, including Crohn's disease (CD) and ulcerative colitis (UC). However, one‐third of the …
[HTML][HTML] Genetically determined high activities of the TNF-alpha, IL23/IL17, and NFkB pathways were associated with increased risk of ankylosing spondylitis
J Sode, S Bank, U Vogel, PS Andersen… - BMC Medical …, 2018 - Springer
Background Ankylosing spondylitis (AS) results from the combined effects of susceptibility
genes and environmental factors. Polymorphisms in genes regulating inflammation may …
genes and environmental factors. Polymorphisms in genes regulating inflammation may …